Cargando…

Role of Adjuvant Thoracic Radiation Therapy and Full Dose Chemotherapy in pN2 Non-small Cell Lung Cancer: Elucidation Based on Single Institute Experience

PURPOSE: The optimal adjuvant therapy modality for treating pN2 non-small cell lung cancer patients has not yet been established. In this study, the authors investigated clinical outcomes following three different adjuvant therapy modalities. MATERIALS AND METHODS: From January 2006 to December 2012...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Hyojung, Oh, Dongryul, Ahn, Yong Chan, Pyo, Hongryull, Noh, Jae Myung, Sun, Jong-Mu, Ahn, Jin Seok, Ahn, Myung-Ju, Park, Keunchil, Kim, Hong Kwan, Choi, Yong Soo, Kim, Jhingook, Zo, Jae Ill, Shim, Young Mog
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Cancer Association 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654153/ https://www.ncbi.nlm.nih.gov/pubmed/28052657 http://dx.doi.org/10.4143/crt.2016.442

Ejemplares similares

Supraclavicular and/or celiac lymph node metastases from thoracic esophageal squamous cell carcinoma did not compromise survival following neoadjuvant chemoradiotherapy and surgery
por: Cho, Won Kyung, et al.
Publicado: (2016)

Adjuvant therapy in stage IIIA-N2 non-small cell lung cancer after neoadjuvant concurrent chemoradiotherapy followed by surgery
por: Shin, Sumin, et al.
Publicado: (2020)

Definitive Bimodality Concurrent Chemoradiotherapy in Patients with Inoperable N2-positive Stage IIIA Non-small Cell Lung Cancer
por: Noh, Jae Myoung, et al.
Publicado: (2015)

Higher thoracic radiation dose is beneficial in patients with extensive small cell lung cancer
por: Yoon, Han Gyul, et al.
Publicado: (2019)

Clinical outcomes of radiation therapy for clinical T4b oesophageal cancer with airway invasion
por: Kim, Hakyoung, et al.
Publicado: (2018)

Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer
por: Yoon, Han Gyul, et al.
Publicado: (2020)

Treatment modality and outcomes among early-stage non-small cell lung cancer patients with COPD: a cohort study
por: Kang, Noeul, et al.
Publicado: (2020)

Concurrent chemo-radiotherapy for unresectable non–small cell lung cancer invading adjacent great vessels on radiologic findings: is it safe?
por: Yoo, Gyu Sang, et al.
Publicado: (2019)

Role of prophylactic cranial irradiation for elderly patients with limited-disease small-cell lung cancer: inverse probability of treatment weighting using propensity score
por: Kim, Tae Gyu, et al.
Publicado: (2019)

High Dose Involved Field Radiation Therapy as Salvage for Loco-Regional Recurrence of Non-Small Cell Lung Cancer
por: Bae, Sun Hyun, et al.
Publicado: (2012)

Salvage proton beam therapy for locoregional recurrence of non-small cell lung cancer
por: Shin, Hyunju, et al.
Publicado: (2021)

Management of chyle leakage after general thoracic surgery: Impact of thoracic duct embolization
por: Jeon, Yeong Jeong, et al.
Publicado: (2021)

A Randomized Phase II Study of Leucovorin/5-Fluorouracil with or without Oxaliplatin (LV5FU2 vs. FOLFOX) for Curatively-Resected, Node-Positive Esophageal Squamous Cell Carcinoma
por: Lim, Sung Hee, et al.
Publicado: (2017)

Predictors of survival in patients who underwent video‐assisted thoracic surgery talc pleurodesis for malignant pleural effusion
por: Yoon, Dong Woog, et al.
Publicado: (2016)

Impact of diffusing lung capacity before and after neoadjuvant concurrent chemoradiation on postoperative pulmonary complications among patients with stage IIIA/N2 non-small-cell lung cancer
por: Shin, Sumin, et al.
Publicado: (2020)

Radiation Therapy Alone in cT1-3N0 Non-small Cell Lung Cancer Patients Who Are Unfit for Surgical Resection or Stereotactic Radiation Therapy: Comparison of Risk-Adaptive Dose Schedules
por: Cho, Won Kyung, et al.
Publicado: (2016)

Is There a Role of Postoperative Radiation Therapy in Completely Resected Stage I/II Thymic Epithelial Tumor?
por: Oh, Dongryul, et al.
Publicado: (2012)

Clinical Outcomes Following Proton and Photon Stereotactic Body Radiation Therapy for Early-Stage Lung Cancer
por: Bae, Bong Kyung, et al.
Publicado: (2022)

Salvage Concurrent Chemo-radiation Therapy for Loco-regional Recurrence Following Curative Surgery of Non-small Cell Lung Cancer
por: Lee, Kyung Hwa, et al.
Publicado: (2019)

The prognostic impact of supraclavicular lymph node in N3-IIIB stage non-small cell lung cancer patients treated with definitive concurrent chemo-radiotherapy
por: Oh, Dongryul, et al.
Publicado: (2017)

Primary Chest Wall Sarcoma: Surgical Outcomes and Prognostic Factors
por: Park, Ilkun, et al.
Publicado: (2019)

Management of post‐pneumonectomy syndrome using tissue expanders
por: Jung, Jae Jun, et al.
Publicado: (2015)

Preoperative Concurrent Radiochemotherapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer
por: Kang, Min Kyu, et al.
Publicado: (2006)

Effect of Radiation Therapy Techniques on Outcome in N3-positive IIIB Non-small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
por: Noh, Jae Myoung, et al.
Publicado: (2016)

Phase II Trial of Combined Durvalumab Plus Tremelimumab with Proton Therapy for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Kim, Hana, et al.
Publicado: (2023)

The prognostic importance of the number of metastases in pulmonary metastasectomy of colorectal cancer
por: Cho, Jong Ho, et al.
Publicado: (2015)

Prognostic impact of lymph node ratio in patients with pT1–2N1M0 non-small cell lung cancer
por: Shin, Sumin, et al.
Publicado: (2020)

Intensive care unit (ICU) readmission after major lung resection: Prevalence, patterns, and mortality
por: Jung, Jae Jun, et al.
Publicado: (2016)

Feasibility and Safety of a New Chest Drain Wound Closure Method with Knotless Sutures
por: Kim, Min Soo, et al.
Publicado: (2018)

EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
por: Park, Song Ee, et al.
Publicado: (2019)

Machine learning model for predicting excessive muscle loss during neoadjuvant chemoradiotherapy in oesophageal cancer
por: Yoon, Han Gyul, et al.
Publicado: (2021)

High-dose radiation therapy alone by moderate hypofractionation for patients with thoracic esophageal squamous cell carcinoma
por: Oh, Dongryul, et al.
Publicado: (2016)

Quantitative CT Variables Enabling Response Prediction in Neoadjuvant Therapy with EGFR-TKIs: Are They Different from Those in Neoadjuvant Concurrent Chemoradiotherapy?
por: Chong, Yousun, et al.
Publicado: (2014)

A retrospective comparative analysis of elderly and younger patients undergoing pulmonary resection for stage I non-small cell lung cancer
por: Park, Byungjoon, et al.
Publicado: (2016)

Esophageal Cancer: Overcome the Hurdles and Reach for the Cure
por: Kim, Hong Kwan, et al.
Publicado: (2020)

Adjuvant Chemotherapy in Patients with Node-Negative Non-Small Cell Lung Cancer with Satellite Pulmonary Nodules in the Same Lobe
por: Park, Jiyoun, et al.
Publicado: (2022)

Prediction of Pathologic Grade and Prognosis in Mucoepidermoid Carcinoma of the Lung Using (18)F-FDG PET/CT
por: Park, Byungjoon, et al.
Publicado: (2015)

Long‐term survival in locally advanced non‐small cell lung cancer invading the great vessels and heart
por: Park, Byungjoon, et al.
Publicado: (2018)

Normal lung sparing Tomotherapy technique in stage III lung cancer
por: Hong, Chae-Seon, et al.
Publicado: (2017)

Feasibility of an Interactive Health Coaching Mobile App to Prevent Malnutrition and Muscle Loss in Esophageal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy: Prospective Pilot Study
por: Yang, Kyungmi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7nvm8d3h3iuims9mi2hplpj9ut